Skip to content

S&P Global SPGI Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp

Segments

By geography

See full
Asia23%+4.5%
Europe23%0.0%
Rest Of World5%-16.7%

Other financials

Income statement

See full
Revenue$4.1B+10.4%
Gross profit$2.9B+11.9%
Operating income$1.8B+16.8%
Net income$1.2B+13.5%
EPS (diluted)$4.12+17.7%

Balance sheet

See full
Cash & equivalents$4.1B+124%
Total debt$15.6B+30.0%
Total equity$31.6B-5.3%
Total assets$62.9B+4.2%

Cash flow

See full
Operating cash flow$1.4B-0.4%
CapEx$27.0M-37.2%
Free cash flow$1.0B+11.0%

Valuation

See full
Market cap$126.21B-22.4%
Enterprise value$134.67B-21.5%
P/E25.6×-13.7×
P/S8.1×-3.1×

Profitability

See full
Gross margin70.5%+0.9pp
Operating margin45.4%+4.2pp
Net margin31.4%+3.2pp
FCF margin35.6%-3.0pp

Returns & leverage

See full
Return on equity15.1%+3.2pp
Debt / equity0.4×0.0×
Current ratio0.7×-0.2×